Taipei, Taiwan

Chun-Man Huang

This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chun-Man Huang. Retrieved from https://idiyas.com/inventor/chun-man-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Chun-Man Huang

Introduction

Chun-Man Huang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibiotic compounds. His work focuses on creating effective treatments for infectious diseases.

Latest Patents

Chun-Man Huang holds a patent for glycopeptide antibiotic compounds, which includes methods for producing these compounds and their various uses. The patent specifically details a teicoplanin derivative that is useful for treating infectious diseases. The structure of this compound is represented by formula (I), which encompasses pharmaceutically acceptable salts, solvates, stereoisomers, derivatives, or prodrugs.

Career Highlights

Huang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at this institution has allowed him to focus on innovative research that bridges the gap between chemistry and medicine. His contributions have been recognized within the scientific community for their potential impact on public health.

Collaborations

Chun-Man Huang has collaborated with esteemed colleagues such as Tsung-Lin Li and Kuan-Hung Lin. These collaborations have fostered a productive research environment, leading to advancements in antibiotic development.

Conclusion

Chun-Man Huang's innovative work in antibiotic compounds exemplifies the importance of research in combating infectious diseases. His contributions continue to influence the field of medicinal chemistry and highlight the significance of collaboration in scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…